A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
Clinical trial NCT04247126 · COMPLETED
Trial details
- NCT number
- NCT04247126
- Sponsor
- Syros Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2023-01-31
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.